L H Block - Concepedia

Author

L H Block

Also Known As

L Block, L H Block, L. -H. Block, L. H. BLOCK, L. H. Block, L.- H. Block, L.-H Block, L.H. Block, LUTZ‐HENNING BLOCK, Lawrence H. BLOCK

Publications

3.3K

Citations

H-Index

113

Concepts

All Affiliations

University of Vienna University Hospital of Basel Vienna General Hospital University of Freiburg Medical University of Vienna

About

L H Block is an author at University of Vienna specializing in medicine, physiology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	32	2K
2	Health Sciences	4	4	260
3	Natural Sciences	3	3	256
4	Engineering	1	1	163
5	Public Health	1	1	133

L H Block

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis Rolf Ziesche, Elisabeth Hofbauer, Karin Wittmann, New England Journal of Medicine	1999	591
Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells Oliver Eickelberg, Michael Roth, Rainer Lörx, Journal of Biological Chemistry	1999	378
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension Ventzislav Petkov, Wilhelm Mosgoeller, Rolf Ziesche, Journal of Clinical Investigation New DrugHypertensionHeart FailureGastrointestinal Peptide HormonePrimary Pulmonary Hypertension	2003	341
Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Michael Roth, Oliver Eickelberg, E. Köhler, Proceedings of the National Academy of Sciences Tissue EngineeringEngineeringBiomedical EngineeringCellular PhysiologyAngiogenesis	1996	163
Ca2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. L H Block, Lyman R. Emmons, Esther Vogt, Proceedings of the National Academy of Sciences Possible Dimeric FormsRecombinant Pdgf HomodimersCellular PhysiologyThrombosisAngiogenesis	1989	138
Long-term Treatment With Oral Sildenafil in Addition to Continuous IV Epoprostenol in Patients With Pulmonary Arterial Hypertension Leopold Stiebellehner, Ventzislav Petkov, Karin Vonbank, CHEST Journal HypertensionPulmonary Arterial HypertensionCardiovascular DiseaseMedicineAntihypertensive Therapy	2003	133
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. L H Block, M. Knorr, Esther Vogt, Proceedings of the National Academy of Sciences Ptdins CycleLipid MovementCellular PhysiologyPtdins TurnoverAutophagy	1988	113
Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. A. Wieczorek, Claudio Rhyner, L H Block Proceedings of the National Academy of Sciences High DensityTumor BiologyMalignant DiseaseMalignant StateMedicine	1985	95
Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells. Walter H. Hörl, Marianne Haag–Weber, A. P. Georgopoulos, Proceedings of the National Academy of Sciences GlycobiologyImmunologyNh2 TerminusUremic SerumInflammation	1990	94
Intracellular interleukin 6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Michael Roth, Markus Nauck, M. Tamm, Proceedings of the National Academy of Sciences ImmunologyBlood CellIntracellular Interleukin 6Cell ProliferationInflammation	1995	88

Page 1